Highland Capital Management (Texas)’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-6,000
Closed -$1.01M 353
2017
Q3
$1.01M Buy
+6,000
New +$907K 0.04% 189
2016
Q3
Sell
-74,093
Closed -$8.1M 376
2016
Q2
$8.1M Sell
74,093
-7,600
-9% -$756K 0.33% 84
2016
Q1
$7.75M Buy
81,693
+33,440
+69% +$2.82M 0.34% 82
2015
Q4
$4.36M Sell
48,253
-21,747
-31% -$1.85M 0.14% 146
2015
Q3
$6.49M Sell
70,000
-83,787
-54% -$7.38M 0.19% 131
2015
Q2
$10.1M Sell
153,787
-77,575
-34% -$5.15M 0.21% 112
2015
Q1
$16.6M Buy
231,362
+139,050
+151% +$7.55M 0.34% 73
2014
Q4
$3.51M Buy
+92,312
New +$2.91M 0.12% 116

Other funds holding ABMD

Highland Capital Management (Texas)'s ABMD Position: Q4 2017 in Review

Highland Capital Management (Texas) sold out of Abiomed Inc (ABMD) in Q4 2017, closing a stake of 6,000 shares — an estimated $1.01M sold.

Highland Capital Management (Texas) first reported a position in ABMD in Q4 2014 and held it in 8 quarters. The position peaked at $16.6M in Q1 2015. 361 funds tracked by Wall St. Rank hold ABMD as of Q4 2017.

  • Highland Capital Management (Texas) reported no remaining Abiomed Inc position as of Q4 2017 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 6,000 Abiomed Inc shares in Q4 2017, an estimated $1.01M.
  • Highland Capital Management (Texas) first reported a position in Abiomed Inc in Q4 2014 and held it in 8 quarters.
  • Highland Capital Management (Texas)'s Abiomed Inc position peaked at $16.6M in Q1 2015.
  • 361 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2017.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2017, filed 14 Feb 2018.